If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,398.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 12.00 (0.861%)
Market Cap: £640.71m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Result of AGM

28 Sep 2022 07:00

RNS Number : 9117A
Cohort PLC
28 September 2022
 

One Waterside Drive

Arlington Business Park

Reading

Berks

RG7 4SW

 

 

 

 

 

28 September 2022

 

 

COHORT PLC

("Cohort" or "the Group")

 

Result of AGM

Cohort, the AIM listed independent technology group, announces that at its Annual General Meeting held earlier today all the resolutions contained within the Notice of Meeting dated 27 September 2022 were duly passed by shareholders.

A summary of the votes received for each resolution is as follows:

 

For1

% For

Against

% Against

Total

% Total2

Withheld3

Ordinary Resolutions

 

1: Accounts

30,785,344

100.00%

1,500

0.00%

30,786,844

74.49%

378

2: Dividend

30,787,222

100.00%

0

0.00%

30,787,222

74.49%

0

3: Remuneration Report

20,198,767

79.91%

5,077,457

20.09%

25,276,224

61.16%

5,510,998

4: Re-elect Edward Lowe

30,780,383

99.99%

1,878

0.01%

30,782,261

74.48%

4,961

5: Re-appoint RSM

30,774,844

99.97%

10,368

0.03%

30,785,212

74.49%

2,010

6: Auditor's Remuneration

30,781,911

100.00%

1,500

0.00%

30,783,411

74.48%

3,811

7: Allot shares

30,370,706

99.95%

14,527

0.05%

30,385,233

73.52%

401,989

Special Resolutions

8: General disapplication of pre-emption rights

30,371,213

99.95%

14,327

0.05%

30,385,540

73.52%

401,682

9: Additional disapplication of pre-emption rights

30,371,013

99.95%

14,327

0.05%

30,385,340

73.52%

401,882

10: Purchase own shares

30,766,827

99.94%

19,865

0.06%

30,786,692

74.49%

530

11: General meeting notice

30,776,659

99.97%

8,000

0.03%

30,784,659

74.49%

2,563

 

Notes:

1. Any proxy appointments which gave discretion to the Chairman have been included in the "for" total.

2. The total number of shares in issue is 41,329,122.

3. A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "for" and "against" a resolution.

4. All percentages are shown to two decimal places.

 

The Board of Cohort notes the 20.09% of votes cast against Resolution 3. The Board will continue to engage with all shareholders to gain a better understanding of their concerns.

 

 

ENDS

 

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

Simon Walther, Finance Director

Raquel McGrath, Company Secretary

Investec Bank Plc (NOMAD and Broker)

020 7597 5970

Daniel Adams, Christopher Baird

MHP Communications

020 3128 8276

Reg Hoare, Ollie Hoare, Pete Lambie

cohort@mhpc.com

 

 

 

NOTES TO EDITORS

 

Cohort plc (www.cohortplc.com) is the parent company of six innovative, agile and responsive businesses based in the UK, Germany and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

Chess Technologies, through its operating businesses Chess Dynamics and Vision4ce, offers surveillance, tracking and fire-control systems to the defence and security markets. A majority stake was acquired by Cohort plc in December 2018. www.chess-dynamics.com 

 

EID designs and manufactures advanced communications systems for naval and military customers. Cohort acquired a majority stake in June 2016. www.eid.pt

 

ELAC SONAR supplies advanced sonar systems and underwater communications to global customers in the naval marketplace. Acquired by Cohort in December 2020. www.elac-sonar.de 

 

MASS is a specialist data technology company serving the defence and security markets, focused on electronic warfare, digital services and training support. Acquired by Cohort in August 2006. www.mass.co.uk

 

MCL designs, sources and supports advanced electronic and surveillance technology for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

 

SEA delivers and supports technology-based products for the defence and transport markets alongside specialist research and training services. Acquired by Cohort in October 2007. www.sea.co.uk

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has headquarters in Reading, Berkshire and employs in total over 1,000 core staff there and at its other operating company sites across the UK, Germany and Portugal.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSEWFUWEESEFU
Date   Source Headline
9th Jul 20267:00 amRNSNotice of Results
1st Jul 20264:43 pmRNSTotal Voting Rights
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.